The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
J Natl Compr Canc Netw. 2012 Oct 1;10(10):1236-71. doi: 10.6004/jnccn.2012.0130.
Most patients with non-small cell lung cancer (NSCLC) are diagnosed with advanced cancer. These guidelines only include information about stage IV NSCLC. Patients with widespread metastatic disease (stage IV) are candidates for systemic therapy, clinical trials, and/or palliative treatment. The goal is to identify patients with metastatic disease before initiating aggressive treatment, thus sparing these patients from unnecessary futile treatment. If metastatic disease is discovered during surgery, then extensive surgery is often aborted. Decisions about treatment should be based on multidisciplinary discussion.
大多数非小细胞肺癌（NSCLC）患者被诊断为晚期癌症。本指南仅包含关于 IV 期 NSCLC 的信息。广泛转移疾病（IV 期）的患者是全身治疗、临床试验和/或姑息治疗的候选者。其目标是在开始积极治疗之前确定患有转移性疾病的患者，从而使这些患者免受不必要的无效治疗。如果在手术过程中发现转移疾病，则通常会中止广泛的手术。关于治疗的决策应基于多学科讨论。
